Exact Mass: 611.2995206
Exact Mass Matches: 611.2995206
Found 234 metabolites which its exact mass value is equals to given mass value 611.2995206,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Lercanidipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Lercanidipine
Lercanidipine is only found in individuals that have used or taken this drug. It is a calcium channel blocker of the dihydropyridine class. It is sold under various commercial names including Zanidip.By deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum, Lercanidipine inhibits the influx of extracellular calcium across the myocardial and vascular smooth muscle cell membranes The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload. C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Dihydroergocristine
Longicalycinin A
A homodetic cyclic peptide composed of glycyl, L-phenylalanyl, L-tyrosyl, L-prolyl and L-phenylalanyl residues joined sequentially to give a 15-membered macrocycle. Isolated from Dianthus superbus var longicalycinus, it exhibits anti-cancer activity.
7,19-Diproanoyldideacetylpyripyropene A
C33H41NO10 (611.2730326000001)
3,7-Diproanoyldideacetylpyripyropene A
C33H41NO10 (611.2730326000001)
3,19-Diproanoyldideacetylpyripyropene A
C33H41NO10 (611.2730326000001)
dihydroergocristine
Ergocristine in which a single bond replaces the double bond between positions 9 and 10. It is used as the mesylate salt for the symptomatic treatment of mental deterioration associated with cerebrovascular insufficiency and in peripheral vascular disease. C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AE - Ergot alkaloids C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Origin: Microbe; SubCategory_DNP: Alkaloids derived from tryptophan, Ergot alkaloids, Clavine alkaloid relative retention time with respect to 9-anthracene Carboxylic Acid is 0.971 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.968 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.966 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.965
Phe Phe Ile Trp
Phe Phe Leu Trp
Phe Phe Trp Ile
Phe Phe Trp Leu
Phe Ile Phe Trp
Phe Ile Trp Phe
Phe Leu Phe Trp
Phe Leu Trp Phe
Phe Pro Trp Tyr
Phe Pro Tyr Trp
Phe Trp Phe Ile
Phe Trp Phe Leu
Phe Trp Ile Phe
Phe Trp Leu Phe
Phe Trp Pro Tyr
Phe Trp Tyr Pro
Phe Tyr Pro Trp
Phe Tyr Trp Pro
His His Arg Tyr
C27H37N11O6 (611.2928142000001)
His His Tyr Arg
C27H37N11O6 (611.2928142000001)
His Asn Arg Trp
C27H37N11O6 (611.2928142000001)
His Asn Trp Arg
C27H37N11O6 (611.2928142000001)
His Arg His Tyr
C27H37N11O6 (611.2928142000001)
His Arg Asn Trp
C27H37N11O6 (611.2928142000001)
His Arg Trp Asn
C27H37N11O6 (611.2928142000001)
His Arg Tyr His
C27H37N11O6 (611.2928142000001)
His Trp Asn Arg
C27H37N11O6 (611.2928142000001)
His Trp Arg Asn
C27H37N11O6 (611.2928142000001)
His Tyr His Arg
C27H37N11O6 (611.2928142000001)
His Tyr Arg His
C27H37N11O6 (611.2928142000001)
Ile Phe Phe Trp
Ile Phe Trp Phe
Ile Met Trp Tyr
Ile Met Tyr Trp
Ile Trp Phe Phe
Ile Trp Met Tyr
Ile Trp Tyr Met
Ile Tyr Met Trp
Ile Tyr Trp Met
Leu Phe Phe Trp
Leu Phe Trp Phe
Leu Met Trp Tyr
Leu Met Tyr Trp
Leu Trp Phe Phe
Leu Trp Met Tyr
Leu Trp Tyr Met
Leu Tyr Met Trp
Leu Tyr Trp Met
Met Ile Trp Tyr
Met Ile Tyr Trp
Met Leu Trp Tyr
Met Leu Tyr Trp
Met Trp Ile Tyr
Met Trp Leu Tyr
Met Trp Tyr Ile
Met Trp Tyr Leu
Met Tyr Ile Trp
Met Tyr Leu Trp
Met Tyr Trp Ile
Met Tyr Trp Leu
Asn His Arg Trp
C27H37N11O6 (611.2928142000001)
Asn His Trp Arg
C27H37N11O6 (611.2928142000001)
Asn Arg His Trp
C27H37N11O6 (611.2928142000001)
Asn Arg Trp His
C27H37N11O6 (611.2928142000001)
Asn Trp His Arg
C27H37N11O6 (611.2928142000001)
Asn Trp Arg His
C27H37N11O6 (611.2928142000001)
Pro Phe Trp Tyr
Pro Phe Tyr Trp
Pro Trp Phe Tyr
Pro Trp Tyr Phe
Pro Tyr Phe Trp
Pro Tyr Trp Phe
Arg His His Tyr
C27H37N11O6 (611.2928142000001)
Arg His Asn Trp
C27H37N11O6 (611.2928142000001)
Arg His Trp Asn
C27H37N11O6 (611.2928142000001)
Arg His Tyr His
C27H37N11O6 (611.2928142000001)
Arg Asn His Trp
C27H37N11O6 (611.2928142000001)
Arg Asn Trp His
C27H37N11O6 (611.2928142000001)
Arg Trp His Asn
C27H37N11O6 (611.2928142000001)
Arg Trp Asn His
C27H37N11O6 (611.2928142000001)
Arg Tyr His His
C27H37N11O6 (611.2928142000001)
Trp Phe Phe Ile
Trp Phe Phe Leu
Trp Phe Ile Phe
Trp Phe Leu Phe
Trp Phe Pro Tyr
Trp Phe Tyr Pro
Trp His Asn Arg
C27H37N11O6 (611.2928142000001)
Trp His Arg Asn
C27H37N11O6 (611.2928142000001)
Trp Ile Phe Phe
Trp Ile Met Tyr
Trp Ile Tyr Met
Trp Leu Phe Phe
Trp Leu Met Tyr
Trp Leu Tyr Met
Trp Met Ile Tyr
Trp Met Leu Tyr
Trp Met Tyr Ile
Trp Met Tyr Leu
Trp Asn His Arg
C27H37N11O6 (611.2928142000001)
Trp Asn Arg His
C27H37N11O6 (611.2928142000001)
Trp Pro Phe Tyr
Trp Pro Tyr Phe
Trp Arg His Asn
C27H37N11O6 (611.2928142000001)
Trp Arg Asn His
C27H37N11O6 (611.2928142000001)
Trp Tyr Phe Pro
Trp Tyr Ile Met
Trp Tyr Leu Met
Trp Tyr Met Ile
Trp Tyr Met Leu
Trp Tyr Pro Phe
Tyr Phe Pro Trp
Tyr Phe Trp Pro
Tyr His His Arg
C27H37N11O6 (611.2928142000001)
Tyr His Arg His
C27H37N11O6 (611.2928142000001)
Tyr Ile Met Trp
Tyr Ile Trp Met
Tyr Leu Met Trp
Tyr Leu Trp Met
Tyr Met Ile Trp
Tyr Met Leu Trp
Tyr Met Trp Ile
Tyr Met Trp Leu
Tyr Pro Phe Trp
Tyr Pro Trp Phe
Tyr Arg His His
C27H37N11O6 (611.2928142000001)
Tyr Trp Phe Pro
Tyr Trp Ile Met
Tyr Trp Leu Met
Tyr Trp Met Ile
Tyr Trp Met Leu
Tyr Trp Pro Phe
(2S)-2-[[2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]acetyl]amino]-N-(4-methyl-2-oxochromen-7-yl)-6-[(2,2,2-trifluoroacetyl)amino]hexanamide
Dihydroergocristine
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.966 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.965 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.968 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.971
(2E,4E,9R)-10-[(4S,4aR,6R,8S,8aR)-4-[[(2S)-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetyl]amino]-8-methoxy-7,7-dimethyl-4a,6,8,8a-tetrahydro-4H-pyrano[3,2-d][1,3]dioxin-6-yl]-9-hydroxydeca-2,4-dienoic acid
Pyripyropene K
C33H41NO10 (611.2730326000001)
A sesquiterpenoid that consists of a heterotetracyclic system linked to a pyridine moiety. Isolated from the fungus, Aspergillus fumigatus, it exhibits inhibitory activity against acyl-CoA:cholesterol acyltransferase 2.
Pyripyropene L
C33H41NO10 (611.2730326000001)
A sesquiterpenoid that consists of a heterotetracyclic system linked to a pyridine moiety. Isolated from the fungus, Aspergillus fumigatus, it exhibits inhibitory activity against acyl-CoA:cholesterol acyltransferase 2.
Pyripyropene J
C33H41NO10 (611.2730326000001)
A sesquiterpenoid that consists of a heterotetracyclic system linked to a pyridine moiety. Isolated from the fungus, Aspergillus fumigatus, it exhibits inhibitory activity against acyl-CoA:cholesterol acyltransferase 2.
(6Ar,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2,5-dimethyl-3-pyrazolecarboxamide
2-[[5-(diaminomethylideneamino)-1-[[3-methyl-1-oxo-1-[[(2S)-1-oxo-3-phenylpropan-2-yl]amino]butan-2-yl]amino]-1-oxopentan-2-yl]carbamoylamino]-3-(4-hydroxyphenyl)propanoic acid
3-[[3-acetyloxy-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid
(8s,15s,21s,24s)-15-[(2r)-butan-2-yl]-6,13,22-trihydroxy-24-isopropyl-4,8-dimethyl-3,10-dioxa-26-thia-7,14,17,23,28,29,30-heptaazapentacyclo[23.2.1.1²,⁵.1⁹,¹².0¹⁷,²¹]triaconta-1(27),2(30),4,6,9(29),11,13,22,25(28)-nonaen-16-one
(5as,6s,7ar,8r,9s,11as,11bs,12r)-8-[(acetyloxy)methyl]-12-hydroxy-5a,8,11a-trimethyl-1-oxo-9-(propanoyloxy)-3-(pyridin-3-yl)-6,7,7a,9,10,11,11b,12-octahydro-2,5-dioxatetraphen-6-yl propanoate
C33H41NO10 (611.2730326000001)
14-(acetyloxy)-6-(2-hydroxy-5h-pyrrol-3-yl)-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadec-7-en-12-yl 2-methylbut-2-enoate
13-deoxo-13 alpha-acetyloxy-1-deoxytaxine b
{"Ingredient_id": "HBIN001165","Ingredient_name": "13-deoxo-13 alpha-acetyloxy-1-deoxytaxine b","Alias": "13-deoxo-13\u03b1-acetyloxy-1-deoxytaxine b","Ingredient_formula": "C35H49NO8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30860;5138","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
[9-(acetyloxy)-12-hydroxy-5a,8,11a-trimethyl-1-oxo-6-(propanoyloxy)-3-(pyridin-3-yl)-6,7,7a,9,10,11,11b,12-octahydro-2,5-dioxatetraphen-8-yl]methyl propanoate
C33H41NO10 (611.2730326000001)
(1s,3s,7s,10r,11s,16r)-7-{[(2s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-11-hydroxy-8,8,10-trimethyl-3-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione
C30H45NO10S (611.2764030000001)
[(5as,6r,7as,8s,9s,11ar,11bs,12r)-6-(acetyloxy)-12-hydroxy-5a,8,11a-trimethyl-1-oxo-9-(propanoyloxy)-3-(pyridin-3-yl)-6,7,7a,9,10,11,11b,12-octahydro-2,5-dioxatetraphen-8-yl]methyl propanoate
C33H41NO10 (611.2730326000001)
(1r,2s,4r,6r,9r,10r,11r,12s,14r,15r,18r)-14-(acetyloxy)-6-(2-hydroxy-5h-pyrrol-3-yl)-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadec-7-en-12-yl (2e)-2-methylbut-2-enoate
8-[(acetyloxy)methyl]-12-hydroxy-5a,8,11a-trimethyl-1-oxo-6-(propanoyloxy)-3-(pyridin-3-yl)-6,7,7a,9,10,11,11b,12-octahydro-2,5-dioxatetraphen-9-yl propanoate
C33H41NO10 (611.2730326000001)
n-{3-[1,8,14-trihydroxy-10-(1h-indol-3-ylmethyl)-6-(4-methylpentyl)-4,11-dioxo-3h,6h,7h,10h,13h,14h,15h,15ah-pyrrolo[2,1-f]1-oxa-4,7,10-triazacyclotridecan-3-yl]propyl}guanidine
C31H45N7O6 (611.3431149999999)
(2r,3r)-3-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-3-{[(1s)-1-{[(1s)-1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-4-(n-hydroxyformamido)butyl]-c-hydroxycarbonimidoyl}-2-hydroxyethyl]-c-hydroxycarbonimidoyl}-2-hydroxypropanoic acid
7-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-11-hydroxy-8,8,10-trimethyl-3-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione
C30H45NO10S (611.2764030000001)
2-[({4-carbamimidamido-1-[(2-methyl-1-{[(2r)-1-oxo-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}propyl)-c-hydroxycarbonimidoyl]butyl}-c-hydroxycarbonimidoyl)amino]-3-(4-hydroxyphenyl)propanoic acid
3,9-dibenzyl-1,4,7,10-tetrahydroxy-12-[(4-hydroxyphenyl)methyl]-3h,6h,9h,12h,15h,16h,17h,17ah-pyrrolo[1,2-a]1,4,7,10,13-pentaazacyclopentadecan-13-one
(2s)-2-({[(1s)-4-carbamimidamido-1-{[(1s)-2-methyl-1-{[(2s)-1-oxo-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}propyl]-c-hydroxycarbonimidoyl}butyl]-c-hydroxycarbonimidoyl}amino)-3-(4-hydroxyphenyl)propanoic acid
10-hydroxy-8-[3-hydroxy-4,8-dimethyl-9-(2-methyl-1,3-oxazol-4-yl)nona-4,6,8-trien-2-yl]-11,16-dimethyl-4,7,12,18-tetraoxatetracyclo[15.3.1.0³,⁵.0¹¹,¹³]henicos-14-ene-6,19-dione
6,13,22-trihydroxy-24-isopropyl-4,8-dimethyl-15-(2-methylpropyl)-3,10-dioxa-26-thia-7,14,17,23,28,29,30-heptaazapentacyclo[23.2.1.1²,⁵.1⁹,¹².0¹⁷,²¹]triaconta-1(27),2(30),4,6,9(29),11,13,22,25(28)-nonaen-16-one
(3s,9s,12r,17ar)-3,9-dibenzyl-1,4,7,10-tetrahydroxy-12-[(4-hydroxyphenyl)methyl]-3h,6h,9h,12h,15h,16h,17h,17ah-pyrrolo[1,2-a]1,4,7,10,13-pentaazacyclopentadecan-13-one
14-(acetyloxy)-6-(5-hydroxy-2h-pyrrol-3-yl)-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadec-7-en-12-yl 2-methylbut-2-enoate
(1r,2s,4r,6r,9r,10r,11r,12s,14r,15r,18r)-14-(acetyloxy)-6-(5-hydroxy-2h-pyrrol-3-yl)-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁸]octadec-7-en-12-yl (2e)-2-methylbut-2-enoate
n-{3-[(3s,10r,14r,15as)-1,8,14-trihydroxy-10-(1h-indol-3-ylmethyl)-6-(4-methylpentyl)-4,11-dioxo-3h,6h,7h,10h,13h,14h,15h,15ah-pyrrolo[2,1-f]1-oxa-4,7,10-triazacyclotridecan-3-yl]propyl}guanidine
C31H45N7O6 (611.3431149999999)
(2s)-2-({[(1s)-4-carbamimidamido-1-{[(1s)-2-methyl-1-{[(2r)-1-oxo-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}propyl]-c-hydroxycarbonimidoyl}butyl]-c-hydroxycarbonimidoyl}amino)-3-(4-hydroxyphenyl)propanoic acid
(3s,9s,12s,17as)-3,9-dibenzyl-1,4,7,10-tetrahydroxy-12-[(4-hydroxyphenyl)methyl]-3h,6h,9h,12h,15h,16h,17h,17ah-pyrrolo[1,2-a]1,4,7,10,13-pentaazacyclopentadecan-13-one
5-(acetyloxy)-3-(5-hydroxy-2-oxopyrrol-3-yl)-6-[6-(2-methoxy-2-oxoethyl)-1,5,5-trimethyl-4-oxocyclohex-2-en-1-yl]-3a-methyl-7-methylidene-hexahydroindeno[1,7a-b]oxiren-4-yl 2-methylpropanoate
C33H41NO10 (611.2730326000001)
(5ar,6r,7ar,8s,9s,11as,11br,12s)-8-[(acetyloxy)methyl]-12-hydroxy-5a,8,11a-trimethyl-1-oxo-6-(propanoyloxy)-3-(pyridin-3-yl)-6,7,7a,9,10,11,11b,12-octahydro-2,5-dioxatetraphen-9-yl propanoate
C33H41NO10 (611.2730326000001)
(8s,15s,21s,24s)-6,13,22-trihydroxy-24-isopropyl-4,8-dimethyl-15-(2-methylpropyl)-3,10-dioxa-26-thia-7,14,17,23,28,29,30-heptaazapentacyclo[23.2.1.1²,⁵.1⁹,¹².0¹⁷,²¹]triaconta-1(27),2(30),4,6,9(29),11,13,22,25(28)-nonaen-16-one
(1s,3s,5r,8s,10s,11r,13r,14e,16r,17r)-10-hydroxy-8-[(2r,3r,4e,6e,8e)-3-hydroxy-4,8-dimethyl-9-(2-methyl-1,3-oxazol-4-yl)nona-4,6,8-trien-2-yl]-11,16-dimethyl-4,7,12,18-tetraoxatetracyclo[15.3.1.0³,⁵.0¹¹,¹³]henicos-14-ene-6,19-dione
[6-(acetyloxy)-12-hydroxy-5a,8,11a-trimethyl-1-oxo-9-(propanoyloxy)-3-(pyridin-3-yl)-6,7,7a,9,10,11,11b,12-octahydro-2,5-dioxatetraphen-8-yl]methyl propanoate
C33H41NO10 (611.2730326000001)
(1ar,3r,3ar,4r,5r,6r,7as)-5-(acetyloxy)-3-(5-hydroxy-2-oxopyrrol-3-yl)-6-[(1s,6r)-6-(2-methoxy-2-oxoethyl)-1,5,5-trimethyl-4-oxocyclohex-2-en-1-yl]-3a-methyl-7-methylidene-hexahydroindeno[1,7a-b]oxiren-4-yl 2-methylpropanoate
C33H41NO10 (611.2730326000001)
2-[({4-carbamimidamido-1-[(2-methyl-1-{[(2s)-1-oxo-3-phenylpropan-2-yl]-c-hydroxycarbonimidoyl}propyl)-c-hydroxycarbonimidoyl]butyl}-c-hydroxycarbonimidoyl)amino]-3-(4-hydroxyphenyl)propanoic acid
(14e)-10-hydroxy-8-[(4e,6e,8e)-3-hydroxy-4,8-dimethyl-9-(2-methyl-1,3-oxazol-4-yl)nona-4,6,8-trien-2-yl]-11,16-dimethyl-4,7,12,18-tetraoxatetracyclo[15.3.1.0³,⁵.0¹¹,¹³]henicos-14-ene-6,19-dione
[(5as,6s,7ar,8r,9s,11ar,11bs,12r)-9-(acetyloxy)-12-hydroxy-5a,8,11a-trimethyl-1-oxo-6-(propanoyloxy)-3-(pyridin-3-yl)-6,7,7a,9,10,11,11b,12-octahydro-2,5-dioxatetraphen-8-yl]methyl propanoate
C33H41NO10 (611.2730326000001)